Business Solutions

Business Solutions

Mastering USP 800 Guidelines for Safe Drug Handling

Mastering USP 800 Guidelines for Safe Drug Handling
Image Source: pexels

You play a crucial role in ensuring safety in healthcare settings, especially when navigating hazardous drug handling with USP 800 PPE. Approximately 8 million healthcare workers in the U.S. are potentially exposed to these drugs annually, which can lead to serious health risks. A table from OSHA shows that over 400 studies document significant workplace exposure risks due to improper handling practices.

Strict adherence to USP 800 guidelines is essential. These guidelines help you navigate hazardous drug handling safely, protecting both you and your patients.

Key Takeaways

  • Follow USP 800 guidelines to ensure safe handling of hazardous drugs. This protects both healthcare workers and patients from exposure risks.

  • Use proper personal protective equipment (PPE) like double gloves and gowns to minimize contamination. Change gloves every 30 minutes to maintain safety.

  • Implement engineering controls such as specialized hoods and closed-system devices. These tools help contain hazardous drugs during preparation.

  • Regular training and education are essential for compliance. Stay updated on safe handling practices and ensure all staff are trained.

  • Conduct compliance audits to identify gaps in procedures. Regular checks help maintain safety standards and improve handling practices.

USP 800 Overview

USP 800 Overview
Image Source: pexels

Key Components of USP 800

USP 800 outlines essential guidelines for handling hazardous drugs safely in healthcare settings. These guidelines focus on protecting healthcare workers, patients, and the environment from the risks associated with hazardous drug exposure. Here are the primary components of USP 800:

Component

Description

Personal Protective Equipment

Use specific ASTM D6978-05 chemotherapy-tested gloves and gowns when handling hazardous drugs.

Engineering Controls

Implement hoods and closed-system transfer devices during medication preparation.

Policies and Procedures

Develop comprehensive policies covering all aspects of hazardous drug handling.

Compliance Importance

Compliance with USP 800 is crucial for several reasons. First, it helps prevent contamination in healthcare environments. Over 100 studies have documented hazardous drug contamination, which poses serious health risks. More than 50 studies have shown hazardous drugs in the urine of healthcare workers, indicating actual exposure.

Additionally, USP 800 compliance protects both patients and healthcare professionals. The standard emphasizes careful handling and storage of drugs that are carcinogenic or toxic. It mandates engineering controls, personal protective equipment (PPE), and surface sampling to monitor contamination risks.

Healthcare facilities must also develop policies for hazardous drug management. This includes creating a list of hazardous drugs, implementing facility and engineering controls, and ensuring personnel are trained in safe handling practices. Failure to comply can lead to administrative sanctions, fines, or even facility closure until compliance is achieved.

By adhering to USP 800 guidelines, you contribute to a safer healthcare environment for everyone involved.

Navigating Hazardous Drug Handling with USP 800 PPE

Navigating Hazardous Drug Handling with USP 800 PPE
Image Source: pexels

Engineering Controls

Engineering controls play a vital role in minimizing exposure to hazardous drugs. These controls include specialized equipment designed to contain or eliminate hazards. According to USP 800, specific engineering controls are necessary for different compounding types. Here’s a summary of the required devices:

Compounding Type

Device Type

USP 800 Guidelines

Nonsterile

C-PEC

Externally ventilated or contain redundant HEPA filters; Containment Ventilated Enclosure, Class I or II Biological Safety Cabinet (BSC), or Compounding Aseptic Containment Isolator (CACI).

 

C-SEC

Externally ventilated; 12 ACPH; 0.01 – 0.03 wc negative pressure

Sterile

C-PEC

Externally vented providing ISO Class 5 or better air quality; Class II (type A2, B1, or B2) or Class III Biological Safety Cabinet (BSC) or Compounding Aseptic Containment Isolator (CACI).

 

C-SEC

ISO Class 7 buffer room with ISO Class 7 ante-room; Externally ventilated; 30 ACPH; 0.01 – 0.03 wc negative pressure or Unclassified containment segregated compounding area; Externally ventilated; 12 ACPH; 0.03 wc negative pressure

Implementing these engineering controls significantly reduces the risk of hazardous drug exposure. However, studies show mixed results regarding their effectiveness. The UK Oncology Nursing Society found insufficient evidence to support or refute the effectiveness of closed systems in clinical settings. In contrast, USP 800 mandates full PPE for handling hazardous drugs, emphasizing a structured approach to safety.

Personal Protective Equipment (PPE) Guidelines

PPE is essential when handling hazardous drugs. USP 800 outlines specific requirements to ensure your safety. Here are the key PPE guidelines:

  1. Gloves: You must wear two pairs of chemotherapy gloves that meet ASTM D6978 standards. Change them every 30 minutes if they become contaminated.

  2. Gowns: Long-sleeved gowns that are open in the back are required. Change them every 2-3 hours.

  3. Eye and Face Protection: Goggles are necessary to protect against spills or splashes.

Additionally, surgical masks are not sufficient. You need an N95 or P-100 respirator to protect against hazardous drug exposure.

Proper glove usage is critical. Studies show that double-gloving significantly reduces glove perforations and enhances protection against hazardous substances. For instance, research indicates that double layers of gloves extend breakthrough times against toxic drugs.

To minimize exposure during doffing, follow these best practices:

  1. Establish a doffing area immediately inside the HD buffer room.

  2. Remove outer sterile gloves inside the C-PEC.

  3. Carefully take off the outer HD gown without contaminating other surfaces.

  4. Sit to remove outer shoe covers, disposing of them properly.

  5. Remove inner gloves by creating a packet to contain them.

  6. Perform hand hygiene thoroughly after doffing.

By adhering to these PPE guidelines, you can significantly reduce the risk of hazardous drug exposure and ensure a safer working environment.

Facility Design and Staff Safety

Design Requirements

To comply with USP 800, your facility must meet specific design requirements for hazardous drug storage and preparation. Here are the key elements:

  • Walls and Surfaces: For non-sterile compounding, ensure surfaces are smooth, impervious, and free from cracks. This prevents contamination and facilitates cleaning.

  • Negative Pressure: Maintain negative pressure in the buffer room. This design ensures hazardous particles are exhausted externally, protecting the pharmacy environment.

  • Dedicated Spaces: Create designated areas for hazardous drug handling. These areas must have at least 12 air changes per hour to contain airborne contaminants.

  • Storage Solutions: Include a refrigerator and chemical storage in the hazardous drug room. While sinks and dishwashers are not required, using storage cabinets with doors is recommended for safe chemical storage.

Implementation Challenges

Implementing these design standards can be challenging. Here are some common obstacles you may face:

  • Facility Upgrades: Upgrading pharmacy spaces can disrupt healthcare operations. You must plan carefully to minimize interruptions.

  • HVAC Compliance: Meeting tightened HVAC requirements adds complexity. Proper engineering controls are necessary to maintain negative pressure.

  • Complex Regulations: Compliance with USP 797 and USP 800 can be lengthy and complicated. Understanding the nuances of both standards is essential.

  • Cost Implications: Upgrading facilities to meet USP 800 requirements involves significant operational and capital costs. For example, modifications to air handling systems and exhaust systems can lead to extensive expenses.

By addressing these design requirements and challenges, you can create a safer environment for handling hazardous drugs. This proactive approach not only protects you but also enhances patient safety.

Ongoing Compliance and Oversight

Training and Education

Continuous training and education are vital for maintaining compliance with USP 800 guidelines. You must stay informed about the latest practices and protocols for handling hazardous drugs. Regular training sessions help reinforce safe handling techniques and ensure that all staff members understand their responsibilities.

Here are some key training requirements specified by USP 800:

Training Requirement

Description

Recurring Competencies

Identify the recurring competencies required by USP 800.

Personal Protective Equipment

Identify the PPE required when working with hazardous drugs.

Disposal Requirements

Identify the requirements for disposal of hazardous drugs and trace contaminated materials.

Deactivation Solutions

Identify the solutions needed to deactivate, decontaminate, clean, and disinfect/sanitize areas where hazardous drugs are handled.

Spill Response

List the steps to take if a hazardous drug spill occurs.

Hazardous Drug List

Summarize the list of hazardous drugs and their risk for exposure.

Exposure Opportunities

Identify potential hazardous drug exposure opportunities.

Exposure Routes

Identify the four ways that exposure to hazardous drugs can occur.

Engineering Controls

List the three types of engineering controls.

Medical Surveillance

Conduct medical surveillance of staff at baseline and continue until exit assessment, including a medical history and follow-up plan for employees demonstrating changes.

Regular training not only enhances knowledge but also improves the use of personal protective equipment (PPE). Studies show that feedback about hazardous drug exposures can lead to increased PPE use among nurses. This highlights the importance of creating a culture of safety and accountability within your facility.

Compliance Audits

Regular compliance audits are essential for ensuring adherence to USP 800 guidelines. These audits help identify gaps in procedures and training, allowing you to address issues before they escalate. Common findings from USP 800 compliance audits include:

Finding Type

Description

Environmental Controls

Hospitals often struggle with maintaining environmental controls in compounding areas.

Staff Training

Ensuring consistent staff training is a common challenge.

Hazardous Drug Handling

Managing the complexities of hazardous drug handling is frequently problematic.

Resource Constraints

Staffing, financial resources, and technology limitations impact compliance efforts.

Many hospitals experience significant procedural gaps in the appropriate aseptic operation of their facilities. These gaps can lead to compliance issues during audits. Therefore, you must prioritize ongoing education and training to mitigate these risks.

To maintain compliance, consider implementing the following strategies:

  1. Standardized Procedures: Use consistent formats across departments to ensure uniformity and clarity for staff.

  2. Accessible SOPs: Store standard operating procedures (SOPs) in easily accessible locations to prevent staff from bypassing important information.

  3. Thorough Training: Provide clear communication and training during SOP implementation to ensure success across disciplines.

  4. Multidisciplinary Collaboration: Engage a team approach that includes various healthcare professionals to enhance compliance.

By focusing on continuous training and regular audits, you can create a safer environment for handling hazardous drugs. This proactive approach not only protects you but also enhances patient safety.

You must continuously adhere to USP 800 guidelines to ensure safety for everyone involved in hazardous drug handling. This commitment fosters a culture of safety and enhances risk mitigation. It leads to better health outcomes for both staff and patients.

To stay informed about updates, follow these steps:

  1. Conduct Hazardous Drug rounds to assess compliance with policies.

  2. Review your facility’s NIOSH hazardous drug list regularly.

  3. Ensure your hazardous drug SOPs and training are up to date.

By prioritizing compliance, you protect yourself and your patients while reducing liability for your healthcare facility.

FAQ

What are hazardous drugs?

Hazardous drugs are medications that can pose risks to healthcare workers and patients. These drugs may cause cancer, reproductive toxicity, or organ toxicity. You must handle them with care to minimize exposure.

Why is USP 800 important?

USP 800 provides guidelines for safely handling hazardous drugs. Compliance protects healthcare workers, patients, and the environment from contamination and exposure risks. Following these guidelines ensures a safer healthcare setting.

How often should I change my gloves?

You should change your gloves every 30 minutes or immediately if they become contaminated. Double-gloving is recommended to enhance protection against hazardous substances.

What training is required for handling hazardous drugs?

You must undergo training on personal protective equipment (PPE), disposal requirements, spill response, and exposure routes. Regular training sessions help reinforce safe handling practices.

What should I do if I experience a spill?

If a hazardous drug spill occurs, follow your facility’s spill response protocol. Ensure you wear appropriate PPE, contain the spill, and notify your supervisor immediately for assistance.

 


Main Oncology Solution:

Related USP 800 PPE Resources:

I. Compliance & Strategic Facility Management

II. Role-Specific Protection & Equipment Selection

III. Operational Safety & Handling Protocols

IV. Workforce Training & Safety Culture

FDA 510(k) K222907 Cleared | Tested for Use with Chemotherapy Drugs

USP <800> Compliant Hand Protection Solutions

Chemotherapy-tested gloves are the most frequently contacted PPE in hazardous drug handling. USP <800> mandates Double Gloving for all compounding and administration tasks. Medtecs N1000 Nitrile Series provides ASTM D6978 tested protection as the foundation of your hand protection protocol.

⚠️ Procurement Warning: Not All "Exam Gloves" Are Equal

Many facilities mistakenly use standard ASTM D6319 exam gloves for chemotherapy handling. This is non-compliant with USP <800>. Only gloves tested to ASTM D6978(chemotherapy-specific permeation standard at 35°C body temperature) are acceptable for antineoplastic drugs.

Medtecs N1000 Series Specifications

Technical Specifications

  • 100% Nitrile (NBR)— Superior chemical resistance vs. latex
  • FDA 510(k) K222907— Specifically labeled 'Use with Chemotherapy Drugs'
  • ASTM D6978 Tested— 35°C body temperature simulation (not 23°C room temp)
  • 9 Chemotherapy Agents— Including Carmustine & Thiotepa (hardest to block)
  • 4-5 mil Thickness— Balance of protection and tactile sensitivity
  • AQL 1.5 (EU) / 2.5 (US)— Pinhole defect rate per ISO 2859-1
  • Size Range— XS-XL (N1000-1 to N1000-5)
  • Finger-Textured Design

    Why N1000? Standard gloves fail as skin heats up. Medtecs N1000 series is tested at 35°C (Body Temperature Simulation) rather than standard room temp (23°C), ensuring the ASTM D6978 chemical barrier holds firm during real-world oncology operations.

    Precision grip on glass vials and syringes without compromising the chemical barrier. Critical for Containment Aseptic Compounding Isolators where tactile feedback is essential.

     

    Micro-Textured

    Fingertip Pattern

    4-5 mil

    Optimal Thickness

    ASTM D6978 Breakthrough Times

    Tested at 35°C (body temperature simulation)

    DrugBreakthroughStatus
    Carmustine

    Highest permeation challenge

    > 30 minPass
    Thiotepa

    High lipophilicity

    > 30 minPass
    Cyclophosphamide

    Common alkylating agent

    > 240 minPass
    Cisplatin

    Nephrotoxic platinum compound

    > 240 minPass
    Doxorubicin

    Anthracycline cardiotoxin

    > 240 minPass
    Paclitaxel

    Taxane microtubule inhibitor

    > 240 minPass
    5-Fluorouracil

    Antimetabolite

    > 240 minPass
    Methotrexate

    Folate antagonist

    > 240 minPass
    Etoposide

    Topoisomerase inhibitor

    > 240 minPass

    Note: Carmustine and Thiotepa are the most challenging due to their small molecular size and high lipophilicity. > 30 min is the minimum ASTM D6978 requirement; Medtecs N1000 exceeds this threshold.

    USP <800> Double Gloving Protocol by Scenario

    Recommended chemotherapy gloves configuration for healthcare personnel

    ScenarioInner GloveOuter GloveChange Frequency
    Sterile Compounding (USP <797>/<800>)N1000 (Chemotherapy-tested) under gown cuffASTM D6978 compliant glove over cuff (sterile-ready options available)Every 30 min or immediately if compromised
    Non-Sterile CompoundingN1000 (Size M) under gown cuffN1000 (Size L) over gown cuffEvery 30 min or between patients
    Administration (Infusion Nurses)N1000 tucked under gownN1000 extending over gown cuffBetween each patient
    Spill Response (>5ml)N1000 Nitrile (chemical barrier)Utility-grade Chemical Resistant GloveAfter spill cleanup complete

    Pro Tip: Using a larger size for the outer glove (e.g., inner M + outer L) reduces hand fatigue during extended compounding sessions—a practice endorsed by experienced oncology pharmacists.

     

    Medtecs Solution Matrix: Tiered Protection for Every Role

    Pharmacy Directors need a tiered approach. From pharmacy techs compounding daily to spill response teams handling waste containment systems—choose the right protection level based on drug categories and workflow requirements.

    Tier 1

    Compounding

    Tier 2

    Surgery/HIPEC

    Tier 3

    Spill/Waste

    Tier 1: Compounding

    IL-4036YKTP (Yellow)

    Oncology Pharmacists, Pharmacy Techs

    Specifications

    Engineered PPSB+PE Laminate: Moisture-Vapor Breathable Technology (MVTR) optimizes thermal comfort while maintaining full barrier protection against oral chemo and routine admixtures.

    Use Case

    Daily Admixture in C-SCA, Handling Oral Chemotherapy, Virtual Hybrid IV Certification.

    Key Features

  • 36gsm PPSB+PE fabric
  • >480 min breakthrough (19 drugs)
  • Heat-sealed seams with tape
  • Knit cuff for glove tuck
  • Low-linting for cleanroom supplies
  • Permeation Test Results*

    carmustine:>480 min
    cyclophosphamide:>480 min
    thiotepa:>480 min

    🧤 The Perfect Pair: Gown + N1000 Gloves

    Double Gloving (Non-Sterile)
    Inner:N1000 (Size M) under gown cuff
    Outer:N1000 (Size L) over gown cuff

    Under-and-Over Technique: Larger outer size reduces hand fatigue

    Tier 2: Surgery/HIPEC

    IL-4063WKTP (White)

    Surgeons, OR Nurses

    Specifications

    63gsm Heavy Duty, AAMI Level 4, ASTM F1671 Viral Barrier.

    Use Case

    HIPEC Surgery, Trauma with Chemo Patients, High-fluid procedures.

    Key Features

  • 63gsm heavy-duty construction
  • ASTM F1671 viral barrier
  • AAMI Level 4 certified
  • Reinforced critical zones
  • Dual chemical + biological protection
  • Permeation Test Results*

    carmustine:>480 min
    viral Barrier:ASTM F1671 Pass
    blood Barrier:ASTM F1670 Pass

    🧤 The Perfect Pair: Gown + N1000 Gloves

    Chemotherapy-Tested Protocol
    Inner:N1000 (ASTM D6978 tested) under gown
    Outer:ASTM D6978 compliant glove (sterile-ready configurations available)

    Under-and-Over Technique: Maintains sterile field + chemo protection

    Tier 3: Spill/Waste

    IL-3063WEHTP (Coverall)

    EVS Staff, Spill Response Teams

    Specifications

    Type 5-B/6-B, Hooded, Taped Seams, Full body coverage. Compatible with Daniels' Sharpsmart protocols.

    Use Case

    Cytotoxic Drug Spills (>5ml), Waste Disposal, Disposing of HD. 100% Polyolefin material ensures Eco-Friendly Incineration (No toxic fumes).

    Key Features

  • Type 5-B/6-B certified
  • Full hood coverage
  • Taped seams throughout
  • Elastic wrists & ankles
  • EN 14126 biological protection
  • Permeation Test Results*

    carmustine:>480 min
    particle Protection:Type 5-B Pass
    spray Protection:Type 6-B Pass

    🧤 The Perfect Pair: Gown + N1000 Gloves

    Heavy Duty Protection
    Inner:N1000 Nitrile (chemical barrier)
    Outer:Utility-grade Chemical Resistant Glove

    Under-and-Over Technique: Outer protects against sharps (broken glass)

    Mandatory Add-ons (USP <800>)

  • Double shoe covers (2 pairs) per USP <800>
  • Chemical-resistant gloves (double gloving)
  • Elastomeric half-mask with multi-gas cartridge
  • Product Specification Comparison Table

    SpecificationIL-4036YKTPIL-4063WKTPIL-3063WEHTP
    Product TypeIsolation GownIsolation GownCoverall
    Weight (gsm)366363
    MaterialPPSB+PEPPSB+PESMS+PE
    AAMI LevelLevel 3Level 4N/A
    Permeation Resistance (19 drugs)*>480 min>480 min>480 min
    ASTM F1671 (Viral)✓ Pass✓ Pass
    Type 5-B/6-B✓ Yes
    Heat-Sealed Seams✓ Yes✓ Yes✓ Yes
    Primary Use CaseCompounding, AdministrationHIPEC, Surgery, TraumaSpill Control, Waste Disposal
    * Permeation resistance tested per ASTM protocols against 19 chemotherapy drugs including Carmustine and Thiotepa. Contact Medtecs for detailed test reports and testing conditions.

     

    Like this post? Tell a friend!

    Copyright Notice

    You may not reproduce, modify, publish, display, transmit, or in any way exploit any content on this website, or use such content to construct any kind of database without prior express written approval by Medtecs Group. For permission to use the content, please contact: pr@medtecs.com 

    Disclaimer 

    The information contained in this article is for general information purposes only. The Company does not guarantee the accuracy, relevance timeliness or completeness of any information, and the Company assumes no responsibility for errors or omission in the content of this article.

    Related Articles
    Scroll to Top
    Welcome to explore the corporate website of Medtecs Group. If you are an investor or a consumer, we kindly invite you to visit the following website for information browsing.

    Contact Us

    Catalog Download

    A short description that introduces visitors to your portfolio.

    Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

    Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

    © 2026 All Rights Reserved.

    我們使用 Cookies 分析技術以提升您的使用者體驗。

    我們使用Cookie分析技術,分析您使用網站的方式,以提升您的使用體驗。若您要繼續使用本網站,您將同意我們使用您的Cookie資訊。更多有關Cookie的使用資訊,可參閱我們的「隱私權政策(EN)」與「使用條款」。

    Thank You for Contacting Medtecs

    Your form has been sent. We will contacting you shortly. Medtecs, Safeguarding Every Tomorrow!